Cholesterol Claim Clarification To Be Covered In Upcoming FDA Guidance
This article was originally published in The Tan Sheet
Executive Summary
"Inconsistencies" in FDA's handling of "philosophically-related" cholesterol claims will be addressed in the agency's upcoming guidance on dietary supplement structure/function claims, the Center for Food Safety & Applied Nutrition's Robert Moore, PhD, told a FDLI meeting on supplement regulation in Washington, D.C. June 26.
You may also be interested in...
OTC Cholesterol Drugs Preferred Over Supplements, NCL Survey Finds
Consumers would use OTC cholesterol-lowering drugs instead of dietary supplements currently marketed as maintaining healthy cholesterol levels, a survey conducted by the National Consumers League finds.
OTC Cholesterol Drugs Preferred Over Supplements, NCL Survey Finds
Consumers would use OTC cholesterol-lowering drugs instead of dietary supplements currently marketed as maintaining healthy cholesterol levels, a survey conducted by the National Consumers League finds.
OTC Cholesterol Drugs Preferred Over Supplements, NCL Survey Finds
Consumers would use OTC cholesterol-lowering drugs instead of dietary supplements currently marketed as maintaining healthy cholesterol levels, a survey conducted by the National Consumers League finds.